Search - tctmd.com

Displaying 181 - 200 of 604

Sort: Relevancy | Date

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

Shelley Wood

June 01, 2020

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

Shelley Wood

March 29, 2020

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Todd Neale

March 28, 2020

News Conference News ACC 2020

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Caitlin E. Cox

March 28, 2020

News Conference News ACC 2020

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

Michael O'Riordan

March 28, 2020

News Daily News

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Todd Neale

March 16, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

Advertisement

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA

More Support for DOAC-Based Double Therapy After PCI for A-fib Patients

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content